Sep 13, 2022 / 12:35PM GMT
Hua Ha - Morgan Stanley, Research Division - Equity Analyst
Okay. Well, thank you, everyone. Welcome. My name is Michael Ha. I managed care and health care services analyst at Morgan Stanley. And our next session is with Centene, one of the largest providers in Medicaid managed care, individual exchange as well as a growing Medicare Advantage business. I'm very pleased to have with us today, Chief Executive Officer and Vice Chairman, Sarah London; and Chief Financial Officer, Drew Asher.
So maybe I'll start with the research disclosure, and then I'll pass it off for some introductory remarks. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So with that said, I'd like to turn it over to Sarah (inaudible) remarks.
Sarah M. London - Centene Corporation - CEO & Director
Great. Thanks,
Centene Corp at Morgan Stanley Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot